These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 17464766)

  • 1. Therapeutic approach by a novel designed anti-inflammatory drug, M2000, in experimental immune complex glomerulonephritis.
    Mirshafiey A; Rehm B; Sotoude M; Razavi A; Abhari RS; Borzooy Z
    Immunopharmacol Immunotoxicol; 2007; 29(1):49-61. PubMed ID: 17464766
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Production of M2000 (β-d-mannuronic acid) and its therapeutic effect on experimental nephritis.
    Mirshafiey A; Rehm B; Abhari RS; Borzooy Z; Sotoude M; Razavi A
    Environ Toxicol Pharmacol; 2007 Jul; 24(1):60-6. PubMed ID: 21783790
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of experimental immune complex glomerulonephritis by sodium alginate.
    Mirshafiey A; Borzooy Z; Abhari RS; Razavi A; Tavangar M; Rehm BH
    Vascul Pharmacol; 2005 Jun; 43(1):30-5. PubMed ID: 15893960
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of experimental arthritis with M2000, a novel designed non-steroidal anti-inflammatory drug.
    Mirshafiey A; Cuzzocrea S; Rehm B; Mazzon E; Saadat F; Sotoude M
    Scand J Immunol; 2005 May; 61(5):435-41. PubMed ID: 15882435
    [TBL] [Abstract][Full Text] [Related]  

  • 5. M2000: a revolution in pharmacology.
    Mirshafiey A; Cuzzocrea S; Rehm BH; Matsuo H
    Med Sci Monit; 2005 Aug; 11(8):PI53-63. PubMed ID: 16049391
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of the immunosuppressive agent, ciclosporin, on experimental immune complex glomerulonephritis in rats.
    Fujita M; Iida H; Asaka M; Izumino K; Takata M; Sasayama S
    Nephron; 1991; 57(2):201-5. PubMed ID: 1826940
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel immunosuppressive therapy by M2000 in experimental multiple sclerosis.
    Mirshafiey A; Matsuo H; Nakane S; Rehm BH; Koh CS; Miyoshi S
    Immunopharmacol Immunotoxicol; 2005; 27(2):255-65. PubMed ID: 16114509
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel therapeutic approach by culture filtrate of Cryptococcus neoformans var. gattii (CneF) in experimental immune complex glomerulonephritis.
    Mirshafiey A; Mehrabian F; Razavi A; Shidfar MR; Namaki S
    Gen Pharmacol; 2000 May; 34(5):311-9. PubMed ID: 11368886
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Anti-tumoral Effect of β-D-Mannuronic Acid (M2000) as a Novel NSAID on Treg Cells Frequency and MMP-2, MMP-9, CCL22 and TGFβ1 Gene Expression in Pre-surgical Breast Cancer Patients.
    Kashefi S; Ahmadi H; Omranipour R; Mahmoodzadeh H; Jafarnezhad-Ansariha F; Tofighi Zavareh F; Mirshafiey A
    Iran J Allergy Asthma Immunol; 2019 Feb; 18(1):80-90. PubMed ID: 30848576
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-aging effects of M2000 (β-D-mannuronic acid) as a novel immunosuppressive drug on the enzymatic and non-enzymatic oxidative stress parameters in an experimental model.
    Hosseini S; Abdollahi M; Azizi G; Fattahi MJ; Rastkari N; Zavareh FT; Aghazadeh Z; Mirshafiey A
    J Basic Clin Physiol Pharmacol; 2017 May; 28(3):249-255. PubMed ID: 28207414
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of the antiplatelet agents ticlopidine and dipyridamole on experimental immune complex glomerulonephritis in rats.
    Izumino K; Iida H; Asaka M; Mizumura Y; Sasayama S
    Nephron; 1986; 43(1):56-61. PubMed ID: 2939358
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Oral Administration Effect of Drug Mannuronic Acid (M2000) on Gene Expression of Matrix and Tissue Inhibitor of Metalloproteinases in Rheumatoid Arthritis Patients.
    Gaafar NAG; Aslani M; Aghazadeh Z; Razavi A; Mirshafiey A
    Curr Drug Discov Technol; 2020; 17(5):704-710. PubMed ID: 31250758
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-diabetic effect of
    Mortazavi-Jahromi SS; Alizadeh S; Javanbakht MH; Mirshafiey A
    Arch Physiol Biochem; 2019 Dec; 125(5):435-440. PubMed ID: 29882437
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemopreventive effect of M2000, a new anti-inflammatory agent.
    Mirshafiey A; Khorramizadeh MR; Saadat F; Rehm BH
    Med Sci Monit; 2004 Oct; 10(10):PI105-9. PubMed ID: 15448610
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decrease in cell proliferation by an matrix metalloproteinase inhibitor, doxycycline, in a model of immune-complex nephritis.
    Saglam F; Celik A; Tayfur D; Cavdar Z; Yilmaz O; Sarioglu S; Kolatan E; Oktay G; Camsari T
    Nephrology (Carlton); 2010 Aug; 15(5):560-7. PubMed ID: 20649877
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preclinical assessment of β-d-mannuronic acid (M2000) as a non-steroidal anti-inflammatory drug.
    Fattahi MJ; Abdollahi M; Agha Mohammadi A; Rastkari N; Khorasani R; Ahmadi H; Tofighi Zavareh F; Sedaghat R; Tabrizian N; Mirshafiey A
    Immunopharmacol Immunotoxicol; 2015; 37(6):535-40. PubMed ID: 26584020
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-angiogenesis effect of β-D-mannuronic acid (M2000) as a novel NSAID with immunosuppressive properties under experimental model.
    Rastegari-Pouyani M; Mostafaie A; Mansouri K; Mortazavi-Jahromi SS; Mohammadi-Motlagh HR; Mirshafiey A
    Clin Exp Pharmacol Physiol; 2018 Apr; 45(4):370-376. PubMed ID: 29266560
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardioprotective effect of β-d-mannuronic acid (M2000) as a novel NSAID on gene expression of oxLDL scavenger receptors in the experimental diabetic model.
    Mortazavi-Jahromi SS; Alizadeh S; Javanbakht MH; Mirshafiey A
    Immunopharmacol Immunotoxicol; 2018 Aug; 40(4):284-289. PubMed ID: 29619884
    [TBL] [Abstract][Full Text] [Related]  

  • 19. β-D-Mannuronic Acid (M2000) as a Landmark in Pharmacology.
    Gaafar NAG; Razavi A; Mirshafiey A
    Curr Drug Discov Technol; 2021; 18(1):47-57. PubMed ID: 31880246
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of the anticomplementary agent, K-76 monocarboxylic acid, on experimental immune complex glomerulonephritis in rats.
    Iida H; Izumino K; Asaka M; Takata M; Mizumura Y; Sasayama S
    Clin Exp Immunol; 1987 Jan; 67(1):130-4. PubMed ID: 3497741
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.